LumiraDx

About

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.

London,England,United Kingdom
1001 - 5000
https://www.lumiradx.com/home

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $14.20M
Industries: Health Care,Health Diagnostics,Medical,Medical Device
Founded date: Jan 1, 2014
Number Of Employee: 1001 - 5000
Operating Status: Active
Stock Symbol: nasdaq:LMDX
Legal Name: LumiraDx Ltd

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance. It offers proven solutions to help achieve health care transformation goals, practically and reliably, in the here and now. The company's clients universally deliver more integrated, more informed, patient-centered care that is safer, more efficient, and with demonstrably better outcomes.

LumiraDx makes diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences, and better value. The diagnostic system platform combines a small, portable instrument, advanced low-cost test strip, and seamless digital connectivity.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$425.46M

LumiraDx has raised a total of $425.46M in funding over 2 rounds. Their latest funding was raised on Dec 14, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 14, 2022	Grant	$14.20M	1	Bill & Melinda Gates Foundation	—	Detail
Mar 1, 2022	Post-IPO Debt	$56.50M	2	UBS O'Connor	—	Detail
Sep 29, 2021	IPO	$115M	—	—	—	Detail
Dec 15, 2020	Funding Round	$164M	—	—	—	Detail
Oct 15, 2019	Debt Financing	$75.15M	—	—	—	Detail